Dyne Therapeutics, Inc. ( DYN ) stock has had a pretty rocky 2025. Year to date, the stock is down about 21% and has relied mainly on hitting milestones as big positive catalysts. The way I now seeI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and chal ...

Dyne Therapeutics, Inc. ( DYN ) stock has had a pretty rocky 2025. Year to date, the stock is down about 21% and has relied mainly on hitting milestones as big positive catalysts. The way I now seeI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and chal ...

Shares of PepGen, Inc. (PEPG) have gained 22.6% over the past four weeks to close the last trading session at $5.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10 indicates a potential upside of 75.4%.The mean estimate comprises six short-term price targets with a standard deviation of $5.83. While the lowest estimate of $3.00 indicates a 47.4% decline from the current pric ...

美股市场表现 - 周三早盘美股涨跌互现 道琼斯指数上涨约100点 涨幅0.23%至47,669.92点 纳斯达克指数下跌0.19%至23,530.68点 标普500指数微涨0.02%至6,842.14点 [1] - 工业股板块领涨 涨幅达0.8% 信息技术股板块表现落后 下跌0.6% [1] 公司业绩与事件 - Chewy Inc 第三季度业绩超预期 调整后每股收益为0.32美元 远超市场一致预期的0.13美元 且处于公司管理层28-33美分的指引区间内 [2] - Chewy Inc 第三季度销售额为31.17亿美元 同比增长8.3% 高于市场一致预期的30.99亿美元 且处于公司管理层30.7-31亿美元指引区间的高端 [2] - Enveric Biosciences Inc 股价大涨102%至11.94美元 原因是其用于治疗精神健康障碍的EVM301系列分子相关专利申请获得了美国专利商标局的授权通知书 [8] - A SPAC III Acquisition Corp 股价飙升336%至45.69美元 [8] - Beasley Broadcast Group Inc 股价大涨135%至9.52美元 [8] - WORK Medical Technology Group LTD 股价暴跌86%至0.7876美元 [8] - Agape ATP Corporation 股价下跌82%至0.2332美元 [8] - Pomdoctor Limited 股价下跌73%至1.4799美元 [8] 大宗商品市场 - 油价下跌0.6%至57.92美元/桶 [4] - 金价下跌0.2%至4,227.60美元/盎司 [4] - 银价上涨0.3%至60.990美元/盎司 [4] - 铜价上涨0.8%至5.3615美元/磅 [4] 全球其他市场 - 欧洲股市涨跌不一 欧元区STOXX 600指数上涨0.1% 西班牙IBEX 35指数上涨0.1% 英国富时100指数上涨0.3% 德国DAX 40指数下跌0.3% 法国CAC 40指数下跌0.4% [5] - 亚洲市场周三多数收跌 日本日经225指数下跌0.10% 香港恒生指数上涨0.42% 中国上证综指下跌0.23% 印度BSE Sensex指数下跌0.32% [6] 宏观经济数据 - 美国第三季度民用工人薪酬成本上涨0.8% 低于上一季度0.9%的涨幅 [7] - 12月第一周抵押贷款申请量环比增长4.8% [9]

POTOMAC, MD / ACCESS Newswire / December 10, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) to develop innovative treatments for Alzheimer's disease, today announced that Ascendiant Capital Markets has issued a coverage report entitled: "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75."All reports on IGC Pharma prep ...

Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect Anixa's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, ...

HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it has submitted a new patent application with the U.S. Patent and Trademark Office (USPTO) titled “Spheroids For Cartilage Repair” covering a proprietary fib ...

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is excited to announce that it has completed release testing of its first Australian-made batch of LaNeo™ MDMA 40mg capsules. “PharmAla is pleased to have completed this first batch of material of Australian-made materials in partnership with o ...

关于内容发布商 - 内容发布商Proactive是一家为全球投资受众提供快速、易获取、信息丰富且可操作的商业与金融新闻内容的机构[2] - 其新闻团队由经验丰富且合格的新闻记者组成，所有内容均独立制作[2] - 公司在全球主要金融和投资中心设有办事处和演播室，包括伦敦、纽约、多伦多、温哥华、悉尼和珀斯[2] 关于内容覆盖范围与专长 - 公司在中小型市值市场领域是专家，同时也向投资社区更新蓝筹股公司、大宗商品及更广泛投资领域的信息[3] - 其提供的内容旨在激发和吸引积极的个人投资者[3] - 团队提供的新闻和独特见解覆盖多个市场领域，包括但不限于生物技术与制药、采矿与自然资源、电池金属、石油与天然气、加密货币以及新兴数字和电动汽车技术[3] 关于内容制作与技术应用 - 公司始终秉持前瞻性思维并积极采用技术[4] - 其人类内容创作者拥有数十年的宝贵专业知识和经验[4] - 团队也会利用技术来协助和增强工作流程[4] - 公司偶尔会使用自动化和软件工具，包括生成式人工智能[5] - 然而，所有发布的内容均由人类编辑和撰写，遵循内容制作和搜索引擎优化的最佳实践[5]

BigBear.ai ( BBAI ) have just made a couple of interesting announcements over the past month. Both announcements point to having a nice foothold in the Middle East. The company first revealed a partnership with Vigilix andI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciati ...